208 related articles for article (PubMed ID: 33808880)
1. Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery.
Perez Diaz N; Lione LA; Hutter V; Mackenzie LS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808880
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor β/δ and γ agonists differentially affect prostaglandin E2 and cytokine synthesis and nutrient transporter expression in porcine trophoblast cells during implantation.
Blitek A; Szymanska M
Theriogenology; 2020 Aug; 152():36-46. PubMed ID: 32361305
[TBL] [Abstract][Full Text] [Related]
3. Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction.
Toral M; Romero M; Jiménez R; Robles-Vera I; Tamargo J; Martínez MC; Pérez-Vizcaíno F; Duarte J
Biochem Pharmacol; 2016 Jun; 110-111():25-36. PubMed ID: 27179975
[TBL] [Abstract][Full Text] [Related]
4. Human Endometrial Stromal Cell Differentiation is Stimulated by PPARβ/δ Activation: New Targets for Infertility?
Yu J; Berga SL; Zou W; Rajakumar A; Man M; Sidell N; Taylor RN
J Clin Endocrinol Metab; 2020 Sep; 105(9):2983-95. PubMed ID: 32594141
[TBL] [Abstract][Full Text] [Related]
5. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
Rodríguez-Calvo R; Serrano L; Coll T; Moullan N; Sánchez RM; Merlos M; Palomer X; Laguna JC; Michalik L; Wahli W; Vázquez-Carrera M
Diabetes; 2008 Aug; 57(8):2149-57. PubMed ID: 18443198
[TBL] [Abstract][Full Text] [Related]
6. Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix metalloproteinases.
Barlaka E; Görbe A; Gáspár R; Pálóczi J; Ferdinandy P; Lazou A
Pharmacol Res; 2015; 95-96():102-10. PubMed ID: 25828396
[TBL] [Abstract][Full Text] [Related]
7. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
[TBL] [Abstract][Full Text] [Related]
8. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and molecular modeling studies of the PPARβ/δ antagonist CC618.
Kaupang Å; Paulsen SM; Steindal CC; Ravna AW; Sylte I; Halvorsen TG; Thoresen GH; Hansen TV
Eur J Med Chem; 2015 Apr; 94():229-36. PubMed ID: 25768705
[TBL] [Abstract][Full Text] [Related]
10. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.
Toral M; Romero M; Jiménez R; Mahmoud AM; Barroso E; Gómez-Guzmán M; Sánchez M; Cogolludo Á; García-Redondo AB; Briones AM; Vázquez-Carrera M; Pérez-Vizcaíno F; Duarte J
Clin Sci (Lond); 2015 Nov; 129(9):823-37. PubMed ID: 26253087
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 5-trifluoromethyl-2-sulfonylpyridine PPARβ/δ antagonists: Effects on the affinity and selectivity towards PPARβ/δ.
Kaupang Å; Kase ET; Vo CX; Amundsen M; Vik A; Hansen TV
Bioorg Med Chem; 2016 Jan; 24(2):247-60. PubMed ID: 26707845
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
[TBL] [Abstract][Full Text] [Related]
13. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
Hollingshead HE; Borland MG; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Carcinogenesis; 2008 Jan; 29(1):169-76. PubMed ID: 17893232
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist.
Shearer BG; Steger DJ; Way JM; Stanley TB; Lobe DC; Grillot DA; Iannone MA; Lazar MA; Willson TM; Billin AN
Mol Endocrinol; 2008 Feb; 22(2):523-9. PubMed ID: 17975020
[TBL] [Abstract][Full Text] [Related]
15. Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARbeta/delta ligand GW0742.
Haskova Z; Hoang B; Luo G; Morgan LA; Billin AN; Barone FC; Shearer BG; Barton ME; Kilgore KS
Inflamm Res; 2008 Jul; 57(7):314-21. PubMed ID: 18622687
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy.
Capozzi ME; McCollum GW; Savage SR; Penn JS
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4197-207. PubMed ID: 23716627
[TBL] [Abstract][Full Text] [Related]
17. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats.
Quintela AM; Jiménez R; Gómez-Guzmán M; Zarzuelo MJ; Galindo P; Sánchez M; Vargas F; Cogolludo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
Free Radic Biol Med; 2012 Aug; 53(4):730-41. PubMed ID: 22683600
[TBL] [Abstract][Full Text] [Related]
18. GW0742 reduces mast cells degranulation and attenuates neurological impairments via PPAR
Lu W; Huang J; Flores J; Li P; Wang W; Liu S; Zhang JH; Tang J
Exp Neurol; 2024 Feb; 372():114615. PubMed ID: 37995951
[TBL] [Abstract][Full Text] [Related]
19. Investigation of binding and activity of perfluoroalkyl substances to the human peroxisome proliferator-activated receptor β/δ.
Li CH; Ren XM; Cao LY; Qin WP; Guo LH
Environ Sci Process Impacts; 2019 Nov; 21(11):1908-1914. PubMed ID: 31332417
[TBL] [Abstract][Full Text] [Related]
20. The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.
Capozzi ME; Savage SR; McCollum GW; Hammer SS; Ramos CJ; Yang R; Bretz CA; Penn JS
Exp Eye Res; 2020 Jan; 190():107885. PubMed ID: 31758977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
